From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations

More than 2000 mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) have been described that confer a range of molecular cell biological and functional phenotypes. Most of these mutations lead to compromised anion conductance at the apical plasma membrane of secretory epitheli...

Descripción completa

Detalles Bibliográficos
Autores principales: Veit, Gudio, Avramescu, Radu G., Chiang, Annette N., Houck, Scott A., Cai, Zhiwei, Peters, Kathryn W., Hong, Jeong S., Pollard, Harvey B., Guggino, William B., Balch, William E., Skach, William R., Cutting, Garry R., Frizzell, Raymond A., Sheppard, David N., Cyr, Douglas M., Sorscher, Eric J., Brodsky, Jeffrey L., Lukacs, Gergely L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society for Cell Biology 2016
Materias:
MBoC Perspective on Cell Biology and Human Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4751594/
https://www.ncbi.nlm.nih.gov/pubmed/26823392
http://dx.doi.org/10.1091/mbc.E14-04-0935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4751594/
https://www.ncbi.nlm.nih.gov/pubmed/26823392
http://dx.doi.org/10.1091/mbc.E14-04-0935

Ejemplares similares